Diabetes, insulin use, and gastric cancer: A population-based analysis of the taiwanese

Journal of Clinical Gastroenterology

Volumn 47, Issue 6, 2013, Pages e60-e64

  Tseng, Chin Hsiao ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diabetes; Gastric cancer; Insulin; National Health Insurance; Taiwan

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; OCCUPATION; PREVALENCE; PRIORITY JOURNAL; REIMBURSEMENT; STOMACH CANCER; TAIWAN;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; STOMACH NEOPLASMS; TAIWAN;

EID: 84879890089     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31827245eb     Document Type: Article

References (24)

1. Giovannucci E, Harlan DM, Archer MC, et al.Diabetes and cancer: a consensus report. Diabetes Care. 2010;33:1674-1685.
2. Tseng CH.Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia. 2011;54:2009-2015.
3. Tseng CH.Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan. Gut. 2011;60:774-779.
4. Kuriki K, Hirose K, Tajima K.Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev. 2007;16:83-89.
5. Inoue M, Iwasaki M, Otani T, et al.Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871-1877.
6. Khan M, Mori M, Fujino Y, et al.Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev. 2006;7:253-259.
7. Gong Y, Yang YS, Zhang XM, et al.ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol. 2012;18:563-569.
8. Rousseau MC, Parent ME, Pollak MN, et al.Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer. 2006;118:2105-2109.
9. Coughlin SS, Calle EE, Teras LR, et al.Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004;159:1160-1167.
10. Lin SW, Freedman ND, Hollenbeck AR, et al.Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev. 2011;20:954-961.
11. Jiang X, Bernstein L, Tseng CC, et al.Diabetes and risk of esophageal and gastric adenocarcinomas. Int J Cancer. 2012;131:1417-1422.
12. National Health Research Institute, Taiwan. Available at:. Accessed September 30, 2010.
13. Hsu PI, Jwo JJ, Yang CL, et al.Association of the myeloperoxidase polymorphism with the risk of gastric cancer. Anticancer Res. 2008;28:1317-1323.
14. Yin M, Hu Z, Tan D, et al.Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis. Am J Transl Res. 2009;1:44-54.
15. Chen CJ, You SL, Lin LH, et al.Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;32 suppl S66-S81.
16. Ojetti V, Migneco A, Silveri NG, et al.The role of H. pylori infection in diabetes. Curr Diabetes Rev. 2005;1:343-347.
17. Vigneri P, Frasca F, Sciacca L, et al.Diabetes and cancer. Endocr Relat Cancer. 2009;16:1103-1123.
18. Tseng CH.Diabetes and non-Hodgkin’s lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan. Ann Oncol. 2012;23:153-158.
19. Tseng CH.Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan. Metabolism. 2012;61:1003-1009.
20. Tseng CH.Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care. 2011;34:616-621.
21. Tseng CH.Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study. BJU Int. 2012;110:668-673.
22. Xirasagar S, Lien YC, Lin HC, et al.Procedure volume of gastric cancer resections versus 5-year survival. Eur J Surg Oncol. 2008;34:23-29.
23. Chie WC, Chang YH, Chen HH.A novel method for evaluation of improved survival trend for common cancer: early detection or improvement of medical care. J Eval Clin Pract. 2007;13:79-85.
24. Wild S, Roglic G, Green A, et al.Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.